ArticleAlzheimer's & dementia (New York, N. Y.)2020

Enriching the design of Alzheimer's disease clinical trials: Application of the polygenic hazard score and composite outcome measures.

Sarah J Banks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.